TENSILON DIN 00855804
Status: Cancelled Post Market
Holder: VALEANT CANADA LP / VALEANT CANADA S.E.C.
Molecule: EDROPHONIUM CHLORIDE
Health Canada record
| Active ingredient(s) | EDROPHONIUM CHLORIDE 10 MG |
|---|---|
| Dosage form | Liquid |
| Route | Intravenous; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | V04CX OTHER DIAGNOSTIC AGENTS |
| Original market date | 31-Dec-1988 |
| Current status date | 08-Jul-2016 |
| Source | Health Canada DPD |
Establishment licence of the holder
Valeant Canada LP Valeant Canada S.E.C. — licence 101282, not currently licensed, last inspection rating C (2016-10-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EDROPHONIUM CHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02188848 | ENLON 10MG/ML | BAXTER CORPORATION | Liquid | EDROPHONIUM CHLORIDE 10 MG | Cancelled Post Market |
| 02056658 | ENLON LIQ IV 10MG/ML | OHMEDA PHARMACEUTICAL PRODUCTS, DIVISION OF BOC CANADA LIMITED | Liquid | EDROPHONIUM CHLORIDE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7124 | 2005-06-22 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for EDROPHONIUM CHLORIDE
1 active FDA Drug Master Files.
Request a quote for TENSILON